Evidence map›Paper›PMID 41353167›Full record

ArticleBMC medical imaging2025

An optimal graph convolutional vision neural network with explainable feature optimization for improved skin cancer detection.

Madhavi Latha Pandala, S Periyanayagi

Abstract read
In one paragraph

Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Madhavi Latha PandalaSchool of Computing Science Engineering and Artificial Intelligence, VIT Bhopal University, Bhopal-Indoor Highway, Kothrikalan, Madhya Pradesh, 466114, India. pandalamadhavilatha@gmail.com.ORCID 0009-0009-0218-2569
S PeriyanayagiSchool of Computing Science Engineering and Artificial Intelligence, VIT Bhopal University, Bhopal-Indoor Highway, Kothrikalan, Madhya Pradesh, 466114, India.ORCID 0000-0001-6870-8214

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite advancements in skin cancer diagnosis procedures, misclassification rates in early detection remain high, leading to delayed treatments and reduced survival rates. Existing manual diagnostic methods are often prone to inter-observer variability and human error, while traditional machine learning models struggle with imbalanced datasets and insufficient feature generalization. To address these challenges, this work proposes an Optimal Skin Cancer Classification Network (OSCC-Net), developed on the International Skin Imaging Collaboration-2019 (ISIC-2019) dataset. The model integrates an Adaptive Minority Over-Sampling Procedure (AMOP) to balance under-represented lesion classes, ensuring robust learning for minority lesion classes. The Stochastic Neighbourhood T-Distilling driven Score-Weighted Class Activation Mapping (STND-SWCAM) framework is introduced for feature analysis. It performs fine-grained lesion localization and interpretability, enabling better understanding of decisions. In the feature selection stage, a Grizzly Bear Fat Increase Optimizer with Density-Based Spatial Neighbourhood Discovery Algorithm (GBFIO-DSNDA) is employed to enhance discriminative feature extraction by eliminating redundant and noisy features. Finally, classification is performed using a Graph Convolutional Vision Neural Network (GC-VNN), which leverages spatial dependencies among lesion attributes for improved decision-making. Experimental evaluation reveals that, OSCC-Net achieves 98.32% accuracy, 98.43% precision, 98.40% recall, and 98.39% F1-Score, marking a substantial improvement over baselines shown in our experiments.

Indexed as

Image Interpretation, Computer-AssistedNeural Networks, ComputerSkin NeoplasmsAlgorithmsHumansAdaptive minority over-sampling procedureFeature selectionGraph convolutional vision neural networkISIC-2019Skin cancer classification

Identifiers

PMID41353167
PMCPMC12797544

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.